Results 31 to 40 of about 24,304 (227)

CO2 lasers in the management of potentially malignant and malignant oral disorders [PDF]

open access: yes, 2012
The CO2 laser was invented in 1963 by Kumar Patel. Since the early 1970s, CO2 laser has proved to be an effective method of treatment for patients with several types of oral lesions, including early squamous cell carcinoma.
Hamdoon, Z, Hopper, C, Jerjes, W
core   +1 more source

Oral leukoplakia: Transmission electron microscopic correlation with clinical types and light microscopy

open access: yesDental Research Journal, 2012
Background: Leukoplakia, is a precancerous lesion that is most commonly encountered in the oral cavity. The grade of dysplasia is presumed to be the most important indicator of malignant potential. There are many promising aspects in advanced methods for
Sandhya Avinash Tamgadge   +3 more
doaj   +1 more source

The role of primary healthcare professionals in oral cancer prevention and detection [PDF]

open access: yes, 2003
AIM: To investigate current knowledge, examination habits and preventive practices of primary healthcare professionals in Scotland, with respect to oral cancer, and to determine any relevant training needs. SETTING: Primary care.
A Mashberg   +24 more
core   +1 more source

Research progress of oral hairy leukoplakia [PDF]

open access: yesKouqiang yixue
Oral hairy leukoplakia is an oral mucosal disease caused by Epstein-Barr virusinfection of oral squamous epithelial cells. Oral hairy leukoplakia presents as a non-removable, corrugated and wrinkled white plaque sometimes with hair-like projections ...
MO Longhui, LIANG Jing, WANG Jiongke, LIU Tiannan, ZENG Xin
doaj   +1 more source

Loss of the Y Chromosome in Oral Potentially Premalignant Disorders Predicts Malignant Progression: An Integrative Cross-Species Multi-Cohort Bioinformatic Study. [PDF]

open access: yesHead Neck
ABSTRACT Background The loss of the Y chromosome (LOY) and the extreme down‐regulation of Y chromosome gene expression (EDY) are frequently observed in oral squamous cell carcinoma (OSCC). However, their roles in oral potentially malignant disorders (OPMDs) are unclear.
Han R   +6 more
europepmc   +2 more sources

Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia

open access: yesMolecular Cancer, 2007
Background Oral leukoplakia is a precancerous change developed in the oral mucosa, and the mechanism that oral leukoplakia becomes malignant through atypical epithelium is not known.
Hata Tsuyoshi   +6 more
doaj   +1 more source

Oral leukoplakia treatment with the carbon dioxide laser: A systematic review of the literature [PDF]

open access: yes, 2016
We conducted a systematic review of the literature to evaluate treatment of oral leukoplakia with the carbon dioxide (CO2) laser. A comprehensive search of studies published between 1981 and 2015 and listed in the PubMed (National Library of Medicine ...
Bescós-Atín, Coro   +3 more
core   +1 more source

Oral leukoplakia: Management protocol for primary health-care providers and family physicians

open access: yesIndian Journal of Community and Family Medicine, 2019
Oral cancer is very common in India. Most of the oral cancers develop on a potentially malignant (precancerous) lesion. Leukoplakia is the most common precancerous lesion in the oral cavity.
Ashok Kumar Jena   +4 more
doaj   +1 more source

Oral cancer in the UK: to screen or not to screen. [PDF]

open access: yes, 1998
Although oral squamous cell carcinoma accounts for only a small proportion of malignant neoplasms in the UK, oral cancer incidence and mortality rates have been rising in recent years.
Rodrigues, Veena
core  

β‐Adrenergic Signaling Promotes Anti‐Tumor Immunity in TP53‐mutant Oral Squamous Cell Carcinoma

open access: yesAdvanced Science, EarlyView.
β‐adrenergic stimulation enhances anti‐tumor immunity in TP53‐deficient oral squamous cell carcinoma by inducing tumor‐derived secretion of CXCL10, which attracts and activates cytotoxic CD8+ T cells. The findings demonstrate that β‐adrenergic signaling alters tumor–immune interactions via CXCL10‐mediated paracrine activation, revealing a neuro‐immune ...
Frederico O. Gleber‐Netto   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy